Influence of diabetes on long‐term outcome among unselected patients with acute coronary events

References

• King H, Aubert RE, Herman WW Global burden of diabetes 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414–1431.
   PubMed Web of Science ®Google Scholar
• Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subject with type 2 diabetes and in nondiabetic subject with and without prior myocardial infarction. N Engl J Med 1998; 339: 229–234.
   PubMed Web of Science ®Google Scholar
• Stamler J, Vaccaro 0, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434–444.
   Google Scholar
• Mak KH, Molitemo DJ, Granger CB, et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1997; 30: 171–179.
   Google Scholar
• Abrahamsson P. Rosengren A, Dellborg M. Improved long term prognosis for patients with unstable coronary syndromes 1988-1995. Eur Heart J 2000; 21: 533–539.
   Google Scholar
• Malmberg K, Yusuf S, Gerstein HC, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: Results of OASIS (Organization to Assess Strategies for Ischemic Syndrome) registry. Circulation 2000; 102: 1014–1019.
   PubMed Web of Science ®Google Scholar
• McGuire D, Emanuelsson H, Granger C, et al. for the GUSTO-lib investigators. Influence of diabetes on clinical outcome across the spectrum of acute coronary syndromes: Findings from GUSTO-lib study. Eur Heart J 2000; 21: 1750–1758.
   Google Scholar
• Mukamal K, Nesto R, Cohen M, et al. Impact of diabetes on long-term survival after acute myocardial infarction. Diabetes Care 2001; 24: 1422–1427.
   PubMed Web of Science ®Google Scholar
• Sala J, Masia R, Gonzalez De Molina FJ, et al. Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission. J Epidemiol Community Health 2002; 56: 707–712.
   Google Scholar
• Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 1994; 343: 311–322.
   PubMed Web of Science ®Google Scholar
• Zuanetti G, Latini R, Maggioni A, et al. Influence of diabetes on mortality in acute myocardial infarction: Data from the GISSI-2 study. J Am Coll Cardiol 1993; 22: 1788-1794.
   Google Scholar
• Evans J, Wang J, Andrew a Comparison of cardiovascular risk between patients with type 2 diabetes and those who had a myocardial infarction: Cross section and cohort studies. BMJ 2002; 324: 939–942.
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel HI). JAMA 2001; 285: 2486–2497.
   PubMed Web of Science ®Google Scholar
• The BARI Investigators Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: The Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1997; 96: 1761-1769.
   Google Scholar
• Faerman I, Faccio E, Milei J, et al. Autonomic neuropathy and painless myocardial infarction in diabetic patients. Histologic evidence of their relationship. Diabetes 1977; 26: 1147–1158.
   Google Scholar
• Stone PH, Muller JE, Hartwell T, et al. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILTS Study Group. JACC 1989; 14: 49–57.
   Google Scholar
• Tschoepe D, Roesen P. Schwippert B, et al. Platelets in diabetes: The role in the hemostatic regulation in atherosclerosis. Semin Thromb Hemost 1993; 19: 122–128.
   PubMed Web of Science ®Google Scholar
• Jokl R, Colwell JA. Arterial thrombosis and atherosclerosis in diabetes. Diabetes Reviews 1997; 5: 316–330.
   Google Scholar
• Zarich S, Waxman S, Freeman RT, et al. Effect of autonomic nervous system dysfunction on the circadian pattern of myocardial ischemia in diabetes mellitus. J Am Coll Cardiol 1994; 24: 956–962.
   PubMed Web of Science ®Google Scholar
• Malmberg K, Norhammar A, Wedel H, et al. Glycometabolic state at admission: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction. Long-term results from the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study. Circulation 1999; 99: 2626–2632.
   Google Scholar
• McGovern P, Pankow J, Shahan E, et al. Recent trends in acute coronary heart disease - mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N Engl J Med 1996; 334: 884–890.
   Google Scholar